<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03929159</url>
  </required_header>
  <id_info>
    <org_study_id>2018-0757</org_study_id>
    <secondary_id>NCI-2019-00833</secondary_id>
    <secondary_id>2018-0757</secondary_id>
    <secondary_id>R01GM122775</secondary_id>
    <nct_id>NCT03929159</nct_id>
  </id_info>
  <brief_title>Correlating MicroRNA Changes With Sepsis Outcomes</brief_title>
  <official_title>Profile of miRNA Changes in Sepsis and Surgical Trauma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>M.D. Anderson Cancer Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institute of General Medical Sciences (NIGMS)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>M.D. Anderson Cancer Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This trial studies how changes in microRNAs may correlate with sepsis outcomes. Sepsis is a&#xD;
      type of severe infection of the blood stream, and its diagnosis may be obscured by many other&#xD;
      conditions such as surgery, trauma, and cancer. MicroRNAs are biomarkers found in the blood&#xD;
      and tissue. Blood samples may help correlate changes in microRNA expression to patient&#xD;
      reactions to a sepsis infection.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PRIMARY OBJECTIVES:&#xD;
&#xD;
      I. To examine whether the cellular and viral micro ribonucleic acid (miRNA) changes in plasma&#xD;
      and peripheral mononuclear blood cells (PMNCs) correlate with the diagnosis and outcome of&#xD;
      sepsis.&#xD;
&#xD;
      SECONDARY OBJECTIVES:&#xD;
&#xD;
      I. To distinguish systemic inflammatory response syndrome (SIRS) without infection from&#xD;
      sepsis and septic shock.&#xD;
&#xD;
      OUTLINE: Patients are assigned to 1 of 2 groups.&#xD;
&#xD;
      GROUP A: Patients undergo blood specimen collection at baseline (before surgery), the day&#xD;
      after surgery, either the day of hospital discharge or the day of sepsis diagnosis, and 6&#xD;
      days after the baseline blood draw if still hospitalized.&#xD;
&#xD;
      GROUP B: Patients undergo blood specimen collection at baseline (day of sepsis diagnosis),&#xD;
      the day after baseline, and on day 7 from baseline if still hospitalized.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 26, 2019</start_date>
  <completion_date type="Anticipated">September 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change in cellular and viral micro ribonucleic acids (miRNAs)</measure>
    <time_frame>Baseline up to day 1</time_frame>
    <description>For each of the cellular and viral miRNAs, samples from patients with sepsis versus (vs.) patients with systemic inflammatory response syndrome (SIRS) without sepsis vs. patients presenting for pre-op evaluation (reference group without SIRS or sepsis) will be compared by one-way analysis of variance. Will compare the miRNA expression intergroup differences.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>7-day mortality rate</measure>
    <time_frame>Baseline up to day 7</time_frame>
    <description>Will be correlated with miRNA changes. Will compare the changes of the miRNAs from baseline to day 1 between the patients who were still alive 7 days after diagnosis of sepsis and those who died within 7 days of sepsis diagnosis.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>T and B cells immune phenotypes</measure>
    <time_frame>Up to 2 years</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">225</enrollment>
  <condition>Septicemia</condition>
  <arm_group>
    <arm_group_label>Group A (biospecimen collection)</arm_group_label>
    <description>Patients undergo blood specimen collection at baseline (before surgery), the day after surgery, either the day of hospital discharge or the day of sepsis diagnosis, and 6 days after the baseline blood draw if still hospitalized.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B (biospecimen collection)</arm_group_label>
    <description>Patients undergo blood specimen collection at baseline (day of sepsis diagnosis), the day after baseline, and on day 7 from baseline if still hospitalized.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Biospecimen Collection</intervention_name>
    <description>Undergo blood biospecimen collection</description>
    <arm_group_label>Group A (biospecimen collection)</arm_group_label>
    <arm_group_label>Group B (biospecimen collection)</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood, plasma&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients electively scheduled for surgical operation requiring anesthesia and&#xD;
        hospitalization of longer than 1 day, or patients with high clinical suspicion of sepsis&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Electively scheduled for surgical operation that require general anesthesia and&#xD;
             expected duration of hospitalization of longer than one day (for patients in&#xD;
             Perioperative Evaluation &amp; Management [POEM]) or high clinical suspicion of sepsis by&#xD;
             the emergency physician (for patients in emergency center)&#xD;
&#xD;
          -  Ability to give informed consent. If the patient is incapacitated and unable to give&#xD;
             informed consent, the next-of-kin or a person who has the power of attorney must be&#xD;
             present for informed consent.&#xD;
&#xD;
          -  For patients in the emergency center only, two or more of the following SIRS criteria:&#xD;
&#xD;
               -  Leukocytes &gt; 12,000/mm^3 or &lt; 4,000/mm^3 or &gt; 10% immature (band) forms, provided&#xD;
                  that no filgrastim or pegfilgrastim was administered within 30 days and no&#xD;
                  leukemia&#xD;
&#xD;
               -  Heart rate &gt; 90 beats/minute (min)&#xD;
&#xD;
               -  Respiratory rate &gt; 20 breaths/min or partial pressure of carbon dioxide (CO2) &lt;&#xD;
                  32 mmHg&#xD;
&#xD;
               -  Oral temperature &gt; 38 degrees Celsius (C) or &lt; 36 degrees C or axillary&#xD;
                  temperature &gt; 37 degrees C or &lt; 35 degrees C&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Inability to give informed consent or a person who has power of attorney for medical&#xD;
             decision is not available&#xD;
&#xD;
          -  Being moribund (for patients in emergency center) or cancellation of surgery (for&#xD;
             patients in POEM)&#xD;
&#xD;
          -  Active &quot;Do Not Resuscitate&quot; or &quot;Do Not Intubate&quot; order&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sai-Ching J Yeung</last_name>
    <role>Principal Investigator</role>
    <affiliation>M.D. Anderson Cancer Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sai-Ching J. Yeung</last_name>
    <phone>713-745-9911</phone>
    <email>syeung@mdanderson.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>M D Anderson Cancer Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sai-Ching J. Yeung</last_name>
      <phone>713-745-9911</phone>
    </contact>
    <investigator>
      <last_name>Sai-Ching J. Yeung</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.mdanderson.org</url>
    <description>MD Anderson Cancer Center Website</description>
  </link>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>April 24, 2019</study_first_submitted>
  <study_first_submitted_qc>April 24, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 26, 2019</study_first_posted>
  <last_update_submitted>September 17, 2021</last_update_submitted>
  <last_update_submitted_qc>September 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sepsis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

